J-Star Holding Co., Ltd. clarified that although shareholders approved a 1-for-10 share consolidation, there is no immediate plan or schedule to execute it. The authorization is a strategic tool to maintain capital flexibility and awaits regulatory review. The Board will decide on timing based on market conditions and shareholder interests. Meanwhile, the company focuses on expanding its carbon fiber drone manufacturing and strengthening supply chains globally.
J-Star Holding Co., Ltd. provides an update on its capital structure authorization and strategic timeline. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Nov 04, 2026 20:41 WIB: Of 83 priced US stocks, 72 rose and 10 fell. Notable movers include AUGO at USD 70.68 (+10.25%), HL at USD 14.45 (+9.39%), and HYMC at USD 17.54 (+9.01%).
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
